Аннотация
Обзор литературы посвящен описанию пищевых продуктов и их компонентов, снижающих риск развития колоректального рака (КРР), механизмов действия данных компонентов, включая влияние на эпигенетические факторы и резистентность к химиотерапии. Метаанализы свидетельствуют о влиянии вегетарианской и средиземноморской диет, потребления помидор, пищевых волокон, овса, витамина D и чеснока на снижение риска КРР. В экспериментах на клеточных линиях КРР и на животных идентифицированы механизмы противоопухолевого действия множества компонентов пищевых растительных продуктов. К ним относятся бета-каротин овощей и фруктов, ликопин томатов, ингибиторы Боумана-Бирка и генистеин сои, бета-глюкан овса, сульфорафан капусты, куркумин, ресвератрол орехов и винограда, гесперидин и диметилнобилетин цитрусовых, кверцетин укропа и лука, сезамин кунжута. Описано влияние сульфорафана, куркумина, диаллилдисульфида чеснока, дииндолилметана капусты брокколи, кукурбитацина В тыквы, эпигаллокатехина чая воздействуя на ДНК-метилтрансферазы и деметилазы гистонов оказывают влияние на эпигенетическую регуляцию клеток КРР. Куркумин, ресвератрол, кверцетин, витамин D, рыбий жир, грецкие орехи, полифенолы сливы и антоцианы черной малины влияют на экспрессию специфических микроРНК в канцерогенезе КРР, что свидетельствует о перспективе использования данных компонентов пищевых продуктов для разработки новых способов таргетной терапии КРР. Возможность комплексного использования описанных продуктов питания в лечении КРР связана также с потенцированием эффекта противоопухолевых препаратов и повышением чувствительности к ним клеток КРР. Данная способность определена для куркумина, ресвератрола, сульфорафана, дииндолилметана, генистеина, кверцетина, омега-3 жирных кислот и эпигаллокатехина. Также имеет значение ограничение мяса, ультрапереработанных и жареных продуктов, трансжирных кислот, стимулирующих развитие КРР. Полученные данные могут быть использованы для диетических рекомендаций врачами-онкологами и для проведения дальнейших клинических исследований.
Библиографические ссылки
Morgan E., Arnold M., Gini A., et al. Global burden of colorectal cancer in 2020 and 2040: incidence and mortality estimates from GLOBOCAN. Gut. 2023; 72(2): 338-344.-DOI: https://doi.org/10.1136/gutjnl-2022-327736.
Amintas S., Dupin C., Boutin J., et al. Bioactive food components for colorectal cancer prevention and treatment: A good match. Crit Rev Food Sci Nutr. 2023; 63(23): 6615-6629.-DOI: https://doi.org/10.1080/10408398.2022.2036095.
Мустафин Р.Н., Хуснутдинова Э.К. Роль ретроэлементов в развитии наследственных опухолевых синдромов. Успехи молекулярной онкологии. 2021; 8(4): 42-52-DOI: https://doi.org/10.17650/2313-805X-2021-8-4-42-52. [Mustafin R.N., Khusnutdinova E.K. The role of retroelements in the development of hereditary tumor syndromes. Advances in Molecular Oncology. 2021; 8(4): 42-52-DOI: https://doi.org/10.17650/2313-805X-2021-8-4-42-52 (In Rus)].
Zhong Y., Zhu Y., Li Q., et al. Association between Mediterranean diet adherence and colorectal cancer: a dose-response meta-analysis. Am J Clin Nutr. 2020; 111(6): 1214-1225.-DOI: https://doi.org/10.1093/ajcn/nqaa083.
Parra-Soto S., Ahumada D., Petermann-Rocha F., et al. Association of meat, vegetarian, pescatarian and fish-poultry diets with risk of 19 cancer sites and all cancer: findings from the UK Biobank prospective cohort study and meta-analysis. BMC Med. 2022; 20(1): 79.-DOI: https://doi.org/10.1186/s12916-022-02257-9.
Jiang Z., Chen H., Li M., et al. Associations between colorectal cancer risk and dietary intake of tomato, tomato products, and lycopene: evidence from a prospective study of 101,680 US adults. Front Oncol. 2023; 13: 1220270.-DOI: https://doi.org/10.3389/fonc.2023.1220270.
Arayici M.E., Mert-Ozupek N., Yalcin F., et al. Soluble and insoluble dietary fiber consumption and colorectal cancer risk: A systematic review and meta-analysis. Nutr Cancer. 2022; 74(7): 2412-2425.-DOI: https://doi.org/10.1080/01635581.2021.2008990.
Kyro C., Skeie G., Loft S., et al. Intake of whole grains from different cereal and food sources and incidence of colorectal cancer in the Scandinavian HELGA cohort. Cancer Causes Control. 2013; 24: 1363-1374.-DOI: https://doi.org/10.1007/s10552-013-0215-z.
Xu Y., Qian M., Hong J., et al. The effect of vitamin D on the occurrence and development of colorectal cancer: a systematic review and meta-analysis. Int J Colorectal Dis. 2021; 36(7): 1329-1344.-DOI: https://doi.org/10.1007/s00384-021-03879-w.
Zhou X., Qian H., Zhang D., Zeng L. Garlic intake and the risk of colorectal cancer: A meta-analysis. Medicine (Baltimore). 2020; 99(1): e18575.-DOI: https://doi.org/10.1097/MD.0000000000018575.
Watling C.Z., Schmidt J.A., Dunneram Y., et al. Risk of cancer in regular and low meat-eaters, fish-eaters, and vegetarians: a prospective analysis of UK Biobank participants. BMC Med. 2022; 20(1): 73.-DOI: https://doi.org/10.1186/s12916-022-02256-w.
de Vogel J., Jonker-Termont D.S., van Lieshout E.M., et al. Green vegetables, red meat and colon cancer: chlorophyll prevents the cytotoxic and hyperproliferative effects of haem in rat colon. Carcinogenesis. 2005; 26(2): 387-93.-DOI: https://doi.org/10.1093/carcin/bgh331.
Chiavarini M., Bertarelli G., Minelli L., Fabiani R. Dietary intake of meat cooking-related mutagens (HCAs) and risk of colorectal adenoma and cancer: A systematic review and meta-analysis. Nutrients. 2017; 9(5): 514.-DOI: https://doi.org/10.3390/nu9050514.
Seyyedsalehi M.S., Mohebbi E., Tourang F., et al. Association of dietary nitrate, nitrite, and n-nitroso compounds intake and gastrointestinal cancers: A systematic review and meta-analysis. Toxics. 2023; 11(2): 190.-DOI: https://doi.org/10.3390/toxics11020190.
Isaksen I.M., Dankel S.N. Ultra-processed food consumption and cancer risk: A systematic review and meta-analysis. Clin Nutr. 2023; 42(6): 919-928.-DOI: https://doi.org/10.1016/j.clnu.2023.03.018.
Kliemann N., Al Nahas A., Vamos E.P., et al. Ultra-processed foods and cancer risk: from global food systems to individual exposures and mechanisms. Br J Cancer. 2022; 127(1): 14-20.-DOI: https://doi.org/10.1038/s41416-022-01749-y.
Bruk M.A., Spirin A.V., Khatipov S.A., Kozlova N.V. Radiation-enhanced thermal depolymerization of polytertrafluoroethylene. High Energy Chemistry. 2004; 38(4): 239-245.-DOI: https://doi.org/10.1023/b:hiec.0000035411.02865.e8.
Consonni D., Straif K., Symons J.M., et al. Cancer risk among tetrafluoroethylene synthesis and polymerization workers. Am. J. Epidemiol. 2013; 178(3): 350-358.-DOI: https://doi.org/10.1093/aje/kws588.
Gamboa-Loira B., López-Carrillo L., Mar-Sánchez Y., et al. Epidemiologic evidence of exposure to polycyclic aromatic hydrocarbons and breast cancer: A systematic review and meta-analysis. Chemosphere. 2022; 290: 133237.-DOI: https://doi.org/10.1016/j.chemosphere.2021.133237
Michels N., Specht I.O., Heitmann B.L., et al. Dietary trans-fatty acid intake in relation to cancer risk: a systematic review and meta-analysis. Nutr Rev. 2021; 79(7): 758-776.-DOI: https://doi.org/10.1093/nutrit/nuaa061.
McGee E.E., Kim C.H., Wang M., et al. Erythrocyte membrane fatty acids and breast cancer risk by tumor tissue expression of immuno-inflammatory markers and fatty acid synthase: a nested case-control study. Breast Cancer Res. 2020; 22(1): 78.-DOI: https://doi.org/10.1186/s13058-020-01316-4.
Lee N.Y., Kim Y., Kim Y.S., et al. β-Carotene exerts anti-colon cancer effects by regulating M2 macrophages and activated fibroblasts. J Nutr Biochem. 2020; 82: 108402.-DOI: https://doi.org/10.1016/j.jnutbio.2020.108402.
Lee K.E., Kwon M., Kim Y.S., et al. β-carotene regulates cancer stemness in colon cancer in vivo and in vitro. Nutr Res Pract. 2022; 16(2): 161-172.-DOI: https://doi.org/10.4162/nrp.2022.16.2.161.
Clemente A., Carmen Marín-Manzano M., Jiménez E., et al. The anti-proliferative effect of TI1B, a major Bowman-Birk isoinhibitor from pea (Pisum sativum L.), on HT29 colon cancer cells is mediated through protease inhibition. Br J Nutr. 2012; 108(1): S135-44.-DOI: https://doi.org/10.1017/S000711451200075X.
Wilczak J., Prostek A., Dziendzikowska K., et al. Oat beta-glucan as a metabolic regulator in early stage of colorectal cancer-a model study on azoxymethane-treated rats. Int J Mol Sci. 2024; 25(9): 4635.-DOI: https://doi.org/10.3390/ijms25094635.
Alqalalwah N.A., Abbas M.M., Abbas M.A., et al. Genistein potentiated the cytotoxic effect of entinostat in colorectal cancer cell lines. Res Pharm Sci. 2025; 20(3): 408-415.-DOI: https://doi.org/10.4103/RPS.RPS_59_24.
Arayici M.E., Basbinar Y., Ellidokuz H. High and low dietary fiber consumption and cancer risk: a comprehensive umbrella review with meta-meta-analysis involving meta-analyses of observational epidemiological studies. Crit. Rev Food Sci Nutr. 2023; 28: 1-14.-DOI: https://doi.org/10.1080/10408398.2023.2298772.
Yin T.F., Wang M., Qing Y., et al. Research progress on chemopreventive effects of phytochemicals on colorectal cancer and their mechanisms. World J Gastroenterol. 2016; 22(31): 7058-68.-DOI: https://doi.org/10.3748/wjg.v22.i31.7058.
Jaiswal A.S., Marlow B.P., Gupta N., Narayan S. Beta-catenin-mediated transactivation and cell-cell adhesion pathways are important in curcumin (diferuylmethane)-induced growth arrest and apoptosis in colon cancer cells. Oncogene. 2002; 21(55): 8414-27.-DOI: https://doi.org/10.1038/sj.onc.1205947.
Vanamala J., Radhakrishnan S., Reddivari L., et al. Resveratrol suppresses human colon cancer cell proliferation and induces apoptosis via targeting the pentose phosphate and the talin-FAK signaling pathways-A proteomic approach. Proteome Sci. 2011; 9(1): 49.-DOI: https://doi.org/10.1186/1477-5956-9-49.
Song M., Lan Y., Wu X., et al. The chemopreventive effect of 5-demethylnobiletin, a unique citrus flavonoid, on colitis-driven colorectal carcinogenesis in mice is associated with its colonic metabolites. Food Funct. 2020; 11(6): 4940-4952.-DOI: https://doi.org/10.1039/d0fo00616e.
El-Deek S.E.M., Abd-Elghaffar S.K.H., Hna R.S., et al. Effect of hesperidin against induced colon cancer in rats: Impact of smad4 and activin a signaling pathway. Nutr Cancer. 2022; 74(2): 697-714.-DOI: https://doi.org/10.1080/01635581.2021.1907424.
Neamtu A.A., Maghiar T.A., Alaya A., et al. A comprehensive view on the quercetin impact on colorectal cancer. Molecules. 2022; 27(6): 1873.-DOI: https://doi.org/10.3390/molecules27061873.
Wang X., Qiao J., Zou C., et al. Sesamin induces cell cycle arrest and apoptosis through p38/C-Jun N-terminal kinase mitogen-activated protein kinase pathways in human colorectal cancer cells. Anticancer Drugs. 2021; 32(3): 248-256.-DOI: https://doi.org/10.1097/CAD.0000000000001031.
Huang Y., Liu Z., Li L., et al. Sesamin inhibits hypoxia-stimulated angiogenesis via the NF-κB p65/HIF-1α/VEGFA signaling pathway in human colorectal cancer. Food Funct. 2022; 13(17): 8989-8997.-DOI: https://doi.org/10.1039/d2fo00345g.
Ben Sghaier M., Pagano A., Mousslim M., et al. Rutin inhibits proliferation, attenuates superoxide production and decreases adhesion and migration of human cancerous cells. Biomed Pharmacother. 2016; 84: 1972-1978.-DOI: https://doi.org/10.1016/j.biopha.2016.11.001.
Cal Dogan T., Aydın Dilsiz S., Canpınar H., Ündeğer Bucurgat Ü. Genistein enhances TRAIL-mediated apoptosis through the inhibition of XIAP and DcR1 in colon carcinoma cells treated with 5-fluorouracil. Turk J Pharm Sci. 2024; 21(1): 7-24.-DOI: https://doi.org/10.4274/tjps.galenos.2023.60543.
Liu L., Qiu Y., Peng Z., et al. Genistein induces ferroptosis in colorectal cancer cells via FoxO3/SLC7A11/GPX4 signaling pathway. J Cancer. 2024; 15(20): 6741-6753.-DOI: https://doi.org/10.7150/jca.95775.
Ji Q., Liu X., Han Z., et al. Resveratrol suppresses epithelial-to-mesenchymal transition in colorectal cancer through TGFβ1/Smads signaling pathway mediated Snail/E-cadherin expression. BMC Cancer. 2015; 15: 97.-DOI: https://doi.org/10.1186/s12885-015-1119-y.
Wang Z., Zhang L., Ni Z., et al. Resveratrol induces AMPK-dependent MDR1 inhibition in colorectal cancer HCT116/L-OHP cells by preventing activation of NF-κB signaling and suppressing cAMP-responsive element transcriptional activity. Tumour Biol. 2015; 36(12): 9499-510.-DOI: https://doi.org/10.1007/s13277-015-3636-3.
Demoulin B., Hermant M., Castrogiovanni C., et al. Resveratrol induces DNA damage in colon cancer cells by poisoning topoisomerase II and activates the ATM kinase to trigger p53-dependent apoptosis. Toxicol In Vitro. 2015; 29(5): 1156-65.-DOI: https://doi.org/10.1016/j.tiv.2015.04.015.
Lei J., Chen J., Chen J., et al. Epigallocatechin-3-gallate induces immunogenic cell death and enhances cancer immunotherapy in colorectal cancer. Biochem Biophys Res Commun. 2024; 736: 150907.-DOI: https://doi.org/10.1016/j.bbrc.2024.150907.
He Z.Y., Shi C.B., Wen H., et al. Upregulation of p53 expression in patients with colorectal cancer by administration of curcumin. Cancer Invest. 2011; 29(3): 208-13.-DOI: https://doi.org/10.3109/07357907.2010.550592.
Carroll R.E., Benya R.V., Turgeon D.K., et al. Phase IIa clinical trial of curcumin for the prevention of colorectal neoplasia. Cancer Prev Res (Phila). 2011; 4(3): 354-64.-DOI: https://doi.org/10.1158/1940-6207.CAPR-10-0098.
Roy S., Deka D., Kondaveeti S.B., et al. An overview of potential of natural compounds to regulate epigenetic modifications in colorectal cancer: a recent update. Epigenetics. 2025; 20(1): 2491316.-DOI: https://doi.org/10.1080/15592294.2025.2491316.
Fasanelli F., Giraudo M.T., Vineis P., et al. DNA methylation, colon cancer and Mediterranean diet: results from the EPIC-Italy cohort. Epigenetics. 2019; 14(10): 977-988.-DOI: https://doi.org/10.1080/15592294.2019.1629230.
Zhou J.W., Wang M., Sun N.X., et al. Sulforaphane-induced epigenetic regulation of Nrf2 expression by DNA methyltransferase in human caco-2 cells. Oncol Lett. 2019; 18(3): 2639-2647.-DOI: https://doi.org/10.3892/ol.2019.10569.
Link A., Balaguer F., Shen Y., et al. Curcumin modulates DNA methylation in colorectal cancer cells. PLoS One. 2013; 8(2): e57709.-DOI: https://doi.org/10.1371/journal.pone.0057709.
Shoaib S., Ansari M.A., Ghazwani M., et al. Prospective epigenetic actions of organo-sulfur compounds against cancer: perspectives and molecular mechanisms. Cancers (Basel). 2023; 15(3): 697.-DOI: https://doi.org/10.3390/cancers15030697.
Zhang J., Zou S., Zhang Y., et al. 3,3'-Diindolylmethane enhances fluorouracil sensitivity via inhibition of pyrimidine metabolism in colorectal cancer. Metabolites. 2022; 12(5): 410.-DOI: https://doi.org/10.3390/metabo12050410.
Mao D., Liu A.H., Wang Z.P., et al. Cucurbitacin B inhibits cell proliferation and induces cell apoptosis in colorectal cancer by modulating methylation status of BTG3. Neoplasma. 2019; 66(4): 593-602.-DOI: https://doi.org/10.4149/neo_2018_180929N729.
Cabang A.B., Fang Y., Morris J., et al. Epigallocatechin gallate inhibits colon cancer cell proliferation by modulating epigenetic enzymes (DNMTs, HDACs, and HATs). Cancer Res. 2014; 74: 410-410.-DOI: https://doi.org/10.1158/1538-7445.AM2014-410.
Patil N., Abba M.L., Zhou C., et al. Changes in methylation across structural and MicroRNA genes relevant for progression and metastasis in colorectal cancer. Cancers (Basel). 2021; 13(23): 5951.-DOI: https://doi.org/10.3390/cancers13235951.
Prendecka-Wróbel M., Pigoń-Zając D., Sondej D., et al. Can dietary actives affect mirnas and alter the course or prevent colorectal cancer? Int J Mol Sci. 2023; 24(12): 10142.-DOI: https://doi.org/10.3390/ijms241210142.
Liu H., Zhang L., Hao L., Fan D. Resveratrol inhibits colorectal cancer cell tumor property by activating the miR-769-5p/MSI1 pathway. Mol Biotechnol. 2025; 67(5): 1893-1907.-DOI: https://doi.org/10.1007/s12033-024-01167-w.
Tili E., Michaille J.J., Alder H., et al. Resveratrol modulates the levels of microRNAs targeting genes encoding tumor-suppressors and effectors of TGFβ signaling pathway in SW480 cells. Biochem. Pharmacol. 2010; 80: 2057-2065.-DOI: https://doi.org/10.1016/j.bcp.2010.07.003.
Del Follo-Martinez A., Banerjee N., Li X., et al. Resveratrol and quercetin in combination have anticancer activity in colon cancer cells and repress oncogenic microRNA-27a. Nutr Cancer. 2013; 65(3): 494-504.-DOI: https://doi.org/10.1080/01635581.2012.725194.
Alvarez-Díaz S., Valle N., Ferrer-Mayorga G., et al. MicroRNA-22 is induced by vitamin D and contributes to its antiproliferative, antimigratory and gene regulatory effects in colon cancer cells. Hum Mol Genet. 2012; 21(10): 2157-65.-DOI: https://doi.org/10.1093/hmg/dds031.
Padi S.K.R., Zhang Q., Rustum Y.M. et al. MicroRNA-627 mediates the epigenetic mechanisms of vitamin D to suppress proliferation of human colorectal cancer cells and growth of xenograft tumors in mice. Gastroenterology. 2013; 145: 437-446.-DOI: https://doi.org/10.1053/j.gastro.2013.04.012.
Davidson L.A., Wang N., Shah M.S., et al. n-3 Polyunsaturated fatty acids modulate carcinogen-directed non-coding microRNA signatures in rat colon. Carcinogenesis. 2009; 30: 2077-2084.-DOI: https://doi.org/10.1093/carcin/bgp245.
Shah M.S., Schwartz S.L., Zhao C., et al. Integrated microRNA and mRNA expression profiling in a rat colon carcinogenesis model: Effect of a chemo-protective diet. Physiol. Genom. 2011; 43: 640-654.-DOI: https://doi.org/10.1152/physiolgenomics.00213.2010.
Tsoukas M.A., Ko B.J., Witte T.R., et al. Dietary walnut suppression of colorectal cancer in mice: Mediation by miRNA patterns and fatty acid incorporation. J Nutr Biochem. 2015; 26: 776-783.-DOI: https://doi.org/10.1016/j.jnutbio.2015.02.009.
Banerjee N., Kim H., Talcott S.T., et al. Plum polyphenols inhibit colorectal aberrant crypt foci formation in rats: Potential role of the miR-143/protein kinase B/mammalian target of rapamycin axis. Nutr Res. 2016; 36: 1105-1113.-DOI: https://doi.org/10.1016/j.nutres.2016.06.008.
Guo J., Yang Z., Zhou H., et al. Upregulation of DKK3 by miR-483-3p plays an important role in the chemoprevention of colorectal cancer mediated by black raspberry anthocyanins. Mol Carcinog. 2020; 59(2): 168-178.-DOI: https://doi.org/10.1002/mc.23138.
Zhang H., Guo J., Mao L., et al. Up-regulation of miR-24-1-5p is involved in the chemoprevention of colorectal cancer by black raspberry anthocyanins. Br J Nutr. 2019; 122(5): 518-526.-DOI: https://doi.org/10.1017/S0007114518003136.
Patel B.B., Gupta D., Elliott A.A., et al. Curcumin targets FOLFOX-surviving colon cancer cells via inhibition of EGFRs and IGF-1R. Anticancer Res. 2010; 30(2): 319-25.
Howells L.M., Sale S., Sriramareddy S.N., et al. Curcumin ameliorates oxaliplatin-induced chemoresistance in HCT116 colorectal cancer cells in vitro and in vivo. Int J Cancer. 2011; 129(2): 476-86.-DOI: https://doi.org/10.1002/ijc.25670.
Aires V., Limagne E., Cotte A.K., et al. Resveratrol metabolites inhibit human metastatic colon cancer cells progression and synergize with chemotherapeutic drugs to induce cell death. Molec Nutr Food Res. 2013; 57: 1170-1181.-DOI: https://doi.org/10.1002/mnfr.201200766.
Kaminski B.M., Weigert A., Brüne B., et al. Sulforaphane potentiates oxaliplatin-induced cell growth inhibition in colorectal cancer cells via induction of different modes of cell death. Cancer Chemother Pharmacol. 2011; 67(5): 1167-78.-DOI: https://doi.org/10.1007/s00280-010-1413-y.
Erzinger M.M., Bovet C., Hecht K.M., et al. Sulforaphane preconditioning sensitizes human colon cancer cells towards the bioreductive anticancer prodrug PR-104A. PLoS One. 2016; 11(3): e0150219.-DOI: https://doi.org/10.1371/journal.pone.0150219.
Zhou Y., Zhang J., Wang K., et al. Quercetin overcomes colon cancer cells resistance to chemotherapy by inhibiting solute carrier family 1, member 5 transporter. Eur J Pharmacol. 2020; 881: 178185.-DOI: https://doi.org/10.1016/j.ejphar.2020.173185.
Volpato M., Hull M.A. Omega-3 polyunsaturated fatty acids as adjuvant therapy of colorectal cancer. Cancer Metastasis Rev. 2018; 37(2-3): 545-555.-DOI: https://doi.org/10.1007/s10555-018-9744-y.

Это произведение доступно по лицензии Creative Commons «Attribution-NonCommercial-NoDerivatives» («Атрибуция — Некоммерческое использование — Без производных произведений») 4.0 Всемирная.
© АННМО «Вопросы онкологии», Copyright (c) 2026
